175 related articles for article (PubMed ID: 34899321)
21. Integrated 3D-QSAR, molecular docking, and molecular dynamics simulation studies on 1,2,3-triazole based derivatives for designing new acetylcholinesterase inhibitors.
El Khatabi K; Aanouz I; El-Mernissi R; Singh AK; Ajana MA; Lakhlifi T; Kumar S; Bouachrine M
Turk J Chem; 2021; 45(3):647-660. PubMed ID: 34385858
[TBL] [Abstract][Full Text] [Related]
22. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
23. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755
[TBL] [Abstract][Full Text] [Related]
24. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
[TBL] [Abstract][Full Text] [Related]
25. QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors.
Kang CM; Liu DQ; Zhao XH; Dai YJ; Cheng JG; Lv YT
J Recept Signal Transduct Res; 2016; 36(1):103-9. PubMed ID: 26416217
[TBL] [Abstract][Full Text] [Related]
26. Theoretical studies on the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib and its derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation.
Zhu J; Ke K; Xu L; Jin J
J Mol Model; 2019 Jul; 25(8):242. PubMed ID: 31338599
[TBL] [Abstract][Full Text] [Related]
27. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.
Zhang G; Ren Y
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423939
[TBL] [Abstract][Full Text] [Related]
28. Computational investigation of imidazopyridine analogs as protein kinase B (Akt1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations.
Gu X; Wang Y; Wang M; Wang J; Li N
J Biomol Struct Dyn; 2021 Jan; 39(1):63-78. PubMed ID: 31838955
[TBL] [Abstract][Full Text] [Related]
29. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
[TBL] [Abstract][Full Text] [Related]
30. Designing of the N-ethyl-4-(pyridin-4-yl)benzamide based potent ROCK1 inhibitors using docking, molecular dynamics, and 3D-QSAR.
Ghosh S; Keretsu S; Cho SJ
PeerJ; 2021; 9():e11951. PubMed ID: 34434664
[TBL] [Abstract][Full Text] [Related]
31. Design of novel dopamine D
Zhang C; Li Q; Meng L; Ren Y
J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
[TBL] [Abstract][Full Text] [Related]
32. Structural optimization of pyrrolopyrimidine BTK inhibitors based on molecular simulation.
Wu J; Li P; Chen X; Liu R; Mu Y; Shen Y; Cheng X; Shu M; Bai Y
J Mol Model; 2023 Nov; 29(12):367. PubMed ID: 37950076
[TBL] [Abstract][Full Text] [Related]
33. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.
Zhao L; Fu L; Li G; Yu Y; Wang J; Liang H; Shu M; Lin Z; Wang Y
Mol Divers; 2023 Jun; 27(3):1123-1140. PubMed ID: 35767128
[TBL] [Abstract][Full Text] [Related]
35. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.
Xu C; Ren Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829
[TBL] [Abstract][Full Text] [Related]
36. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
Liu G; Wang W; Wan Y; Ju X; Gu S
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
[TBL] [Abstract][Full Text] [Related]
37. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
38. Investigations of retinoic acid receptor-related orphan receptor-gamma t (RORγt) agonists: a combination of 3D-QSAR, molecular docking and molecular dynamics.
Chen Q; Wang F; Zhou B
J Biomol Struct Dyn; 2021 Jul; 39(10):3501-3514. PubMed ID: 32375589
[TBL] [Abstract][Full Text] [Related]
39. Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.
Balasubramanian PK; Balupuri A; Cho SJ
Arch Pharm Res; 2016 Mar; 39(3):328-39. PubMed ID: 26699616
[TBL] [Abstract][Full Text] [Related]
40. Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques.
Huang S; Feng K; Ren Y
Medchemcomm; 2019 Jan; 10(1):101-115. PubMed ID: 30774858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]